A link between autoimmune disorders and tooth enamel defects revealed
07. 12. 2023
In a groundbreaking study published in Nature, an international team of researchers has discovered a crucial link between autoimmune disorders and defects in tooth enamel development. This study sheds light on the poorly understood conditions of Amelogenesis Imperfecta in patients with Autoimmune Polyglandular Syndrome Type-1 (APS-1) and Celiac Disease.
Ameloblasts, the cells responsible for tooth enamel formation, rely on several proteins to create a durable outer layer for our teeth. When these proteins are attacked by the body's immune system, it leads to Amelogenesis Imperfecta, a condition characterized by weakened, discolored, and easily damaged teeth. This condition has long puzzled the medical community, but the new study led by Jakub Abramson from the Weizmann Institute in Israel offers unprecedented insights.
The research team, including notable contributions from Dr. Jan Prochazka from Czech Center for Phenogenomics, has utilized advanced technology to analyze tooth phenotypes, shedding light on the processes disrupting enamel mineralization in autoimmune conditions. The study reveals that most patients with APS-1 and Celiac Disease develop autoantibodies, particularly of the IgA isotype, against ameloblast-specific proteins. This results in a breakdown of the body's tolerance to these proteins, leading to compromised enamel formation. In Celiac Disease, this phenomenon appears to be linked to a loss of tolerance to intestinal antigens that are also present in enamel tissue. These findings suggest a novel type of IgA-dependent autoimmune disorder, which the researchers have collectively termed "autoimmune amelogenesis imperfecta."
The Czech Centre for Phenogenomics (CCP), at the Institute of Molecular Genetics, led by Radislav Sedlacek is a hub of excellence in genetic research, uniquely integrating genetic engineering, advanced phenotyping, and state-of-the-art imaging within a controlled animal housing environment. The CCP is renowned for its creation of sophisticated mouse and rat models, essential in dissecting genetic disorders and testing medical interventions. As an active member of global consortia like IMPC and INFRAFRONTIER, the CCP contributes to an international effort to map gene functions and their implications in human diseases.
Read also
- Scientists discover new species of rare fungi thanks to arsenic analysis
- MICAL1 plays a key role in cellular dynamics by controlling the cytoskeleton
- Groundbreaking study maps brain’s recovery process after stroke
- IOCB Prague expands overseas, opens a new branch in Boston
- Speedier and more effective treatment of serious illnesses
- Scientists from IOCB Prague help to improve medical drugs
- Newly discovered regenerative cells may revolutionize wound healing
- Genetic mixing as a path to survival
- Powerful winter lightning discharges triggered prolonged whistling around the Earth
- Czech discovery writes a new chapter in electrochemistry textbooks
Contacts for Media
Markéta Růžičková
Public Relations Manager
+420 777 970 812
Eliška Zvolánková
+420 739 535 007
Martina Spěváčková
+420 733 697 112